[{"NetIncomeLoss_2_Q2_USD":-102300000.0,"RestructuringSettlementAndImpairmentProvisions_2_Q2_USD":194200000.0,"LongTermDebt_0_Q2_USD":2056300000.0,"AssetsCurrent_0_Q2_USD":3191300000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":1300000.0,"ProceedsFromIssuanceOfSeniorLongTermDebt_2_Q2_USD":79200000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":1000000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q2_USD":119400000.0,"InventoryRawMaterialsAndSupplies_0_Q2_USD":84100000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-9000000.0,"PaymentsForRestructuring_2_Q2_USD":13800000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-214800000.0,"InventoryFinishedGoods_0_Q2_USD":439500000.0,"IncreaseDecreaseInOperatingCapital_2_Q2_USD":-205700000.0,"RestrictedCashCurrent_0_Q2_USD":10700000.0,"SaleAndLeasebackTransactionGainLossNet_1_Q2_USD":45600000.0,"CommitmentsAndContingencies_0_Q2_USD":0.0,"LongTermDebtCurrent_0_Q2_USD":25900000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":344800000.0,"DeferredFinanceCostsNet_0_Q2_USD":16600000.0,"ShareBasedCompensation_2_Q2_USD":19400000.0,"StockholdersEquityOther_1_Q2_USD":300000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":27800000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-41100000.0,"Assets_0_Q2_USD":9876000000.0,"RestructuringCharges_2_Q2_USD":2400000.0,"PaymentsForSoftware_2_Q2_USD":59600000.0,"OperatingLeaseLeaseIncomeLeasePayments_2_Q2_USD":27800000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":24100000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":295900000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":628600000.0,"ContractWithCustomerLiability_0_Q2_USD":122000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":162800000.0,"CommonStockSharesIssued_0_Q2_shares":398899013.0,"InventoryGross_0_Q2_USD":1099000000.0,"EquityMethodInvestments_0_Q2_USD":19600000.0,"InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0_Q2_USD":-21000000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-23900000.0,"AccountsReceivableNetCurrent_0_Q2_USD":543900000.0,"InventoryLIFOReserve_0_Q2_USD":33700000.0,"DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1_Q2_USD":1000000.0,"DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_2_Q2_USD":2300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":413200000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-42600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":408500000.0,"RepaymentsOfLongTermLinesOfCredit_2_Q2_USD":377800000.0,"NumberOfCountriesInWhichEntityOperates_0_Q2_country":90.0,"EarningsPerShareBasic_1_Q2_USD":-0.13,"EarningsPerShareBasic_2_Q2_USD":-0.25,"DeferredFinanceCostsGross_0_Q2_USD":27300000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":59400000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-1800000.0,"CommonStockValue_0_Q2_USD":0.0,"ProceedsFromIssuanceOrSaleOfEquity_2_Q2_USD":1219900000.0,"OtherReceivablesNetCurrent_0_Q2_USD":72900000.0,"Liabilities_0_Q2_USD":3224100000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1391100000.0,"OtherAssetsNoncurrent_0_Q2_USD":283900000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":49000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":100600000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-25400000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-143400000.0,"CostsAndExpenses_1_Q2_USD":663400000.0,"CostsAndExpenses_2_Q2_USD":1388900000.0,"BusinessCombinationIntegrationRelatedCosts_1_Q2_USD":111100000.0,"BusinessCombinationIntegrationRelatedCosts_2_Q2_USD":187400000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":903900000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.309,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.294,"DepreciationDepletionAndAmortization_2_Q2_USD":162400000.0,"BusinessExitCosts1_2_Q2_USD":700000.0,"BusinessExitCosts1_1_Q2_USD":100000.0,"CommonStockSharesAuthorized_0_Q2_shares":5000000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":586300000.0,"NonoperatingIncomeExpense_2_Q2_USD":46800000.0,"RestructuringReserveAccrualAdjustment1_2_Q2_USD":-700000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":3200000.0,"AccountsPayableCurrent_0_Q2_USD":242500000.0,"LiabilitiesCurrent_0_Q2_USD":835400000.0,"GainLossOnDispositionOfAssets_1_Q2_USD":0.0,"NonoperatingIncomeExpense_1_Q2_USD":47900000.0,"GainLossOnDispositionOfAssets_2_Q2_USD":3800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":413200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":408500000.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":51300000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":163600000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":49600000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":20300000.0,"InventoryWorkInProcess_0_Q2_USD":575400000.0,"InterestExpense_2_Q2_USD":41300000.0,"InterestExpense_1_Q2_USD":24800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":1401800000.0,"NetIncomeLoss_1_Q2_USD":-53200000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":924100000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-14200000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q2_USD":-6000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_2_Q2_USD":-17400000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":65500000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"NoncurrentAssets_0_Q2_USD":1186800000.0,"AdditionalPaidInCapital_0_Q2_USD":6886100000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":2432700000.0,"LongTermDebtNoncurrent_0_Q2_USD":2030400000.0,"SeveranceCosts1_1_Q2_USD":600000.0,"SeveranceCosts1_2_Q2_USD":1000000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":107400000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8300000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":126200000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_1_Q2_USD":3500000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":19200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":57200000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":9876000000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-78400000.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1_Q2_USD":-3100000.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_2_Q2_USD":-3100000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":164000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2_Q2_USD":1500000.0,"RestructuringReserve_0_Q2_USD":8800000.0,"InventoryNet_0_Q2_USD":1065300000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2_Q2_USD":-59900000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q2_USD":-20700000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1244000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q2_USD":1100000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":208900000.0,"OtherLiabilitiesCurrent_0_Q2_USD":321700000.0,"StockholdersEquity_0_Q2_USD":6651900000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-77100000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-144900000.0,"Goodwill_0_Q2_USD":3044000000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":4600000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":942100000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":65100000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":125600000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.13,"EarningsPerShareDiluted_2_Q2_USD":-0.25,"CommonStockSharesOutstanding_0_Q2_shares":398899013.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":1056700000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-19400000.0,"PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0_Q2_USD":83900000.0,"ProceedsFromHedgeInvestingActivities_2_Q2_USD":32700000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":7300000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_2_Q2_USD":3500000.0,"LitigationReserve_0_Q2_USD":0.0,"Ticker":"ELAN","CIK":"1739104","name":"ELANCO ANIMAL HEALTH INC","OfficialName":"Elanco Animal Health Incorporated Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"12367077748.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200730"}]